Fundz
Back to Investors

Track Frazier Life Sciences's Investment Activity

Get real-time alerts when Frazier Life Sciences makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $59/mo
F

Frazier Life Sciences

Other
Total Deals
22
Recent (90d)
3
Total Capital
$3.0B
Co-Investors
140
N

Novo Holdings

Biotechnology
series b
$130.0M

Jul 22, 2026

R

RQ Bio

series a
$115.0M

Jun 24, 2026

c

cAMPfield Therapeutics

BiotechnologySan Diego, United States
series a
$180.0M

Jun 18, 2026

S

Sidewinder Therapeutics

Biotechnology
series b
$137.0M

Apr 8, 2026

P

Parabilis Medicines

BiotechnologyCambridge, United States
series f
$305.0M

Jan 8, 2026

17+ more investments

View all 22 deals by Frazier Life Sciences

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.